Ventripoint’s technology in routine clinical practice”. “Matt has excelled in past assignments and will be key in evolving Ventripoint to becoming a market driven organization,” said Ventripoint’s CEO Hugh MacNaught. “Our focus is developing actionable insights on how to drive adoption of Ventripoint’s technology in routine clinical practice”.
Added Dobson: “Ventripoint's proposition is unique, offering a revolutionary mix of accuracy, efficiency, and user-friendliness in cardiac imaging using artificial intelligence. This affordable tool promises to advance heart health management, making heart scans with cMRI levels of accuracy available to more people, at a fraction of the cost and with results in minutes.”